Yale University
The investigator is testing a virtual environment to address prevention of HIV-related comorbidities.
Cardiovascular Diseases
Gaming in a virtual environment
NA
The primary aims of this study are to test the feasibility, acceptability and preliminary effects of a VE to address prevention of HIV-related comorbidities. A waitlist control feasibility clinical trial will be conducted. We will assign (N=80) eligible participants and ensure balanced allocation to intervention and control groups over the intervention period. We hypothesize that the VE will be feasible and acceptable to persons living with HIV, and that they will apply their VE learning to real-life situations and health behaviors for prevention of HIV-related comorbidities.
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 80 participants |
| Masking : | NONE |
| Primary Purpose : | PREVENTION |
| Official Title : | LEveraging A viRtual eNvironment (LEARN) to Enhance Prevention of HIV-related Comorbidities in At-risk Minority MSM |
| Actual Study Start Date : | 2023-05-10 |
| Estimated Primary Completion Date : | 2025-07-31 |
| Estimated Study Completion Date : | 2025-07-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 30 Years to 65 Years |
| Sexes Eligible for Study: | MALE |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Yale University
Orange, Connecticut, United States, 06477